700 University Avenue North Toronto, Ontario, M5G 1Z5 CanadaMBC — a directnetwork company — is the official Scientist.com outlet of directnetwork GmbH, a Swiss precision‑medicine CRO focused on simplifying and accelerating access to high‑quality human biospecimens, cell lines, and real‑world data. Our work bridges the gap between biobanks, clinical sites, and biotech innovators, enabling faster and more cost‑effective translational research and preclinical development. We provide ethically sourced, well‑characterized human biospecimens—including fresh material—as well as real‑world data representing diverse ethnic backgrounds and homogeneity criteria. Our network of clinical centers and biobanks spans EU and non‑EU Europe, Asia, North America, and Australia, ensuring broad geographic coverage and access to diverse patient populations. Our portfolio includes disease‑specific samples (e.g., blood, PBMCs, and other matrices) paired with matched healthy controls to support robust study design. Our mission is to empower partners to accelerate drug discovery, validation, and development while reducing operational complexity, timelines, and cost. In addition to biospecimen procurement, we collaborate with a specialized downstream analytics partner offering advanced multi‑omics, bioinformatics, and data‑integration capabilities. This enables clients to move seamlessly from sample acquisition to high‑value scientific insights.

Rohini Sector 5 Main Road Rohini, Delhi, 110086 IndiaMBC — a directnetwork company — is the official Scientist.com outlet of directnetwork GmbH, a Swiss precision‑medicine CRO focused on simplifying and accelerating access to high‑quality human biospecimens, cell lines, and real‑world data. Our work bridges the gap between biobanks, clinical sites, and biotech innovators, enabling faster and more cost‑effective translational research and preclinical development. We provide ethically sourced, well‑characterized human biospecimens—including fresh material—as well as real‑world data representing diverse ethnic backgrounds and homogeneity criteria. Our network of clinical centers and biobanks spans EU and non‑EU Europe, Asia, North America, and Australia, ensuring broad geographic coverage and access to diverse patient populations. Our portfolio includes disease‑specific samples (e.g., blood, PBMCs, and other matrices) paired with matched healthy controls to support robust study design. Our mission is to empower partners to accelerate drug discovery, validation, and development while reducing operational complexity, timelines, and cost. In addition to biospecimen procurement, we collaborate with a specialized downstream analytics partner offering advanced multi‑omics, bioinformatics, and data‑integration capabilities. This enables clients to move seamlessly from sample acquisition to high‑value scientific insights.

D-2 Kondali Main Road Sector 8, Uttar Pradesh, 201301 IndiaMBC — a directnetwork company — is the official Scientist.com outlet of directnetwork GmbH, a Swiss precision‑medicine CRO focused on simplifying and accelerating access to high‑quality human biospecimens, cell lines, and real‑world data. Our work bridges the gap between biobanks, clinical sites, and biotech innovators, enabling faster and more cost‑effective translational research and preclinical development. We provide ethically sourced, well‑characterized human biospecimens—including fresh material—as well as real‑world data representing diverse ethnic backgrounds and homogeneity criteria. Our network of clinical centers and biobanks spans EU and non‑EU Europe, Asia, North America, and Australia, ensuring broad geographic coverage and access to diverse patient populations. Our portfolio includes disease‑specific samples (e.g., blood, PBMCs, and other matrices) paired with matched healthy controls to support robust study design. Our mission is to empower partners to accelerate drug discovery, validation, and development while reducing operational complexity, timelines, and cost. In addition to biospecimen procurement, we collaborate with a specialized downstream analytics partner offering advanced multi‑omics, bioinformatics, and data‑integration capabilities. This enables clients to move seamlessly from sample acquisition to high‑value scientific insights.

3 Ulica Karnegijeva Beograd, Centralna Srbija, 11120 SerbiaMBC — a directnetwork company — is the official Scientist.com outlet of directnetwork GmbH, a Swiss precision‑medicine CRO focused on simplifying and accelerating access to high‑quality human biospecimens, cell lines, and real‑world data. Our work bridges the gap between biobanks, clinical sites, and biotech innovators, enabling faster and more cost‑effective translational research and preclinical development. We provide ethically sourced, well‑characterized human biospecimens—including fresh material—as well as real‑world data representing diverse ethnic backgrounds and homogeneity criteria. Our network of clinical centers and biobanks spans EU and non‑EU Europe, Asia, North America, and Australia, ensuring broad geographic coverage and access to diverse patient populations. Our portfolio includes disease‑specific samples (e.g., blood, PBMCs, and other matrices) paired with matched healthy controls to support robust study design. Our mission is to empower partners to accelerate drug discovery, validation, and development while reducing operational complexity, timelines, and cost. In addition to biospecimen procurement, we collaborate with a specialized downstream analytics partner offering advanced multi‑omics, bioinformatics, and data‑integration capabilities. This enables clients to move seamlessly from sample acquisition to high‑value scientific insights.

20 Dornistrasse Sachseln, Obwalden, 6072 SwitzerlandMBC — a directnetwork company — is the official Scientist.com outlet of directnetwork GmbH, a Swiss precision‑medicine CRO focused on simplifying and accelerating access to high‑quality human biospecimens, cell lines, and real‑world data. Our work bridges the gap between biobanks, clinical sites, and biotech innovators, enabling faster and more cost‑effective translational research and preclinical development. We provide ethically sourced, well‑characterized human biospecimens—including fresh material—as well as real‑world data representing diverse ethnic backgrounds and homogeneity criteria. Our network of clinical centers and biobanks spans EU and non‑EU Europe, Asia, North America, and Australia, ensuring broad geographic coverage and access to diverse patient populations. Our portfolio includes disease‑specific samples (e.g., blood, PBMCs, and other matrices) paired with matched healthy controls to support robust study design. Our mission is to empower partners to accelerate drug discovery, validation, and development while reducing operational complexity, timelines, and cost. In addition to biospecimen procurement, we collaborate with a specialized downstream analytics partner offering advanced multi‑omics, bioinformatics, and data‑integration capabilities. This enables clients to move seamlessly from sample acquisition to high‑value scientific insights.